182 related articles for article (PubMed ID: 15899773)
1. Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis.
Ni H; Barosi G; Rondelli D; Hoffman R
Am J Clin Pathol; 2005 Jun; 123(6):833-9. PubMed ID: 15899773
[TBL] [Abstract][Full Text] [Related]
2. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
Straetmans N; Ma DD; Nevell DF; Arthur C
Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
[TBL] [Abstract][Full Text] [Related]
3. CD34+ progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue.
Thiele J; Kvasnicka HM; Czieslick C
Ann Hematol; 2002 Feb; 81(2):86-9. PubMed ID: 11907788
[TBL] [Abstract][Full Text] [Related]
4. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
[TBL] [Abstract][Full Text] [Related]
5. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
Siebolts U; Thiele J; Zander T; Ditschkowski M; Beelen DW; Kröger N; Fehse B; Wickenhauser C
Oncol Rep; 2008 Jan; 19(1):287-92. PubMed ID: 18097609
[TBL] [Abstract][Full Text] [Related]
6. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of the original content of CD34(+) cells for enrichment of hematopoietic progenitor cells from bone marrow harvests by the apheresis procedure.
Itoh T; Minegishi M; Kudo Y; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Miura J; Inoue Y; Kameoka J; Suwabe N; Imaizumi M; Okuda M; Tsuchiya S
J Clin Apher; 2006 Oct; 21(3):176-80. PubMed ID: 16619225
[TBL] [Abstract][Full Text] [Related]
8. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
Thiele J; Kvasnicka HM; Zerhusen G; Vardiman J; Diehl V; Luebbert M; Schmitt-Graeff A
Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958
[TBL] [Abstract][Full Text] [Related]
9. Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
Antonenas V; Garvin F; Webb M; Sartor M; Bradstock KF; Gottlieb D
Cytotherapy; 2006; 8(2):158-65. PubMed ID: 16698689
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1).
Guglielmelli P; Zini R; Bogani C; Salati S; Pancrazzi A; Bianchi E; Mannelli F; Ferrari S; Le Bousse-Kerdilès MC; Bosi A; Barosi G; Migliaccio AR; Manfredini R; Vannucchi AM
Stem Cells; 2007 Jan; 25(1):165-73. PubMed ID: 16990584
[TBL] [Abstract][Full Text] [Related]
11. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
Kröger N; Thiele J; Zander A; Schwerdtfeger R; Kobbe G; Bornhäuser M; Bethge W; Schubert J; de Witte T; Kvasnicka HM;
Exp Hematol; 2007 Nov; 35(11):1719-22. PubMed ID: 17976523
[TBL] [Abstract][Full Text] [Related]
12. Histopathological bone marrow changes after reduced-intensity hematopoietic stem cell transplantation for follicular lymphoma involving bone marrow.
Maeda T; Shiozawa E; Saito B; Usui T; Nakashima H; Hattori N; Adachi D; Yanagisawa K; Kawakami K; Nakamaki T; Tomoyasu S; Yamochi-Onizuka T; Takimoto M; Ota H
Pathol Int; 2007 Jun; 57(6):378-82. PubMed ID: 17539969
[TBL] [Abstract][Full Text] [Related]
13. CD34+ cell responsiveness to stromal cell-derived factor-1alpha underlies rate of engraftment after peripheral blood stem cell transplantation.
Marquez-Curtis LA; Turner AR; Larratt LM; Letcher B; Lee SF; Janowska-Wieczorek A
Transfusion; 2009 Jan; 49(1):161-9. PubMed ID: 18954402
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
[TBL] [Abstract][Full Text] [Related]
15. Local irradiation prior to stem cell harvest has no influence on CD34+ yield: a quantitative analysis.
Rinn JP; Schwella N; Wollmer E; Jaques G; Heinzel-Gutenbrunner M; Strassmann G; Gross MW; Movassaghi K; Neubauer A; Ritter M
Ann Hematol; 2006 Jan; 85(1):38-44. PubMed ID: 16012838
[TBL] [Abstract][Full Text] [Related]
16. The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis.
Xu M; Bruno E; Chao J; Ni H; Lindgren V; Nunez R; Mahmud N; Finazzi G; Fruchtman SM; Popat U; Liu E; Prchal JT; Rondelli D; Barosi G; Hoffman R
Blood; 2005 Feb; 105(4):1699-705. PubMed ID: 15471948
[TBL] [Abstract][Full Text] [Related]
17. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation.
Thiele J; Kvasnicka HM; Dietrich H; Stein G; Hann M; Kaminski A; Rathjen N; Metz KA; Beelen DW; Ditschkowski M; Zander A; Kroeger N
Histol Histopathol; 2005 Jul; 20(3):879-89. PubMed ID: 15944939
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic peripheral blood cell transplantation for hypereosinophilic syndrome with myelofibrosis.
Vazquez L; Caballero D; Cañizo CD; Lopez C; Hernandez R; Gonzalez I; Flores T; San Miguel JF
Bone Marrow Transplant; 2000 Jan; 25(2):217-8. PubMed ID: 10673685
[TBL] [Abstract][Full Text] [Related]
20. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
